RGD Reference Report - 17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

17Beta-estradiol decreases hypoxic induction of erythropoietin gene expression.

Authors: Mukundan, H  Resta, TC  Kanagy, NL 
Citation: Mukundan H, etal., Am J Physiol Regul Integr Comp Physiol 2002 Aug;283(2):R496-504.
RGD ID: 625649
Pubmed: PMID:12121863   (View Abstract at PubMed)
DOI: DOI:10.1152/ajpregu.00573.2001   (Journal Full-text)

Exposure to chronic hypoxia induces erythropoietin (EPO) production to facilitate oxygen delivery to hypoxic tissues. Previous studies from our laboratory found that ovariectomy (OVX) exacerbates the polycythemic response to hypoxia and treatment with 17beta-estradiol (E2-beta) inhibits this effect. We hypothesized that E2-beta decreases EPO gene expression during hypoxia. Because E2-beta can induce nitric oxide (NO) production and NO can attenuate EPO synthesis, we further hypothesized that E2-beta inhibition of EPO gene expression is mediated by NO. These hypotheses were tested in OVX catheterized rats treated with E2-beta (20 microg/day) or vehicle for 14 days and exposed to 8 or 12 h of hypoxia (12% O(2)) or normoxia. We found that E2-beta treatment significantly decreased EPO synthesis and gene expression during hypoxia. E2-beta treatment did not induce endothelial NO synthase (eNOS) expression in the kidney but potentiated hypoxia-induced increases in plasma nitrates. We conclude that E2-beta decreases hypoxic induction of EPO. However, this effect does not appear to be related to changes in renal eNOS expression.

Gene Ontology Annotations    Click to see Annotation Detail View

Biological Process
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
response to hypoxia  TAS 625649 RGD 

Objects Annotated

Genes (Rattus norvegicus)
Epo  (erythropoietin)


Additional Information